Intravenous Fosfomycin for Systemic Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Infections

Intravenous Fosfomycin for Systemic Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Infections

Human <i>Pseudomonas</i> infections have high morbidity and mortality rates. <i>Pseudomonas</i> bacteria can cause sepsis or septic shock; they produce biofilm and commonly exhibit a multidrug-resistant phenotype. The choice of antimicrobial therapy in many cases is challengi...

Full description

Bibliographic Details
Main Authors: Giuseppe Pipitone, Stefano Di Bella, Alberto Enrico Maraolo, Guido Granata, Milo Gatti, Luigi Principe, Alessandro Russo, Andrea Gizzi, Rita Pallone, Antonio Cascio, Chiara Iaria
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Antibiotics
Subjects:
fosfomycin
<i>Pseudomonas aeruginosa</i>
multidrug resistance
difficult-to-treat <i>P. aeruginosa</i>
Online Access:https://www.mdpi.com/2079-6382/12/12/1653

Internet

https://www.mdpi.com/2079-6382/12/12/1653

Similar Items